Carmolex Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Carmolex General Information

Description

Developer of medical drugs intended to serve with unique technology to advance drug discovery projects. The company develops technology for large-scale design, synthesis, and validation of small molecule protein antagonists, enabling medical professionals with the largest chemical libraries available in the world to our client's drug discovery projects.

Contact Information

Website
www.carmolex.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Webster Hall 4415 Fifth Avenue
  • Suite 106
  • Pittsburgh, PA 15213
  • United States
+1 (412)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Webster Hall 4415 Fifth Avenue
  • Suite 106
  • Pittsburgh, PA 15213
  • United States
+1 (412)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carmolex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Startup
3. Equity Crowdfunding 02-Nov-2013 Completed Startup
2. Seed Round 15-Mar-2013 $750K $1.35M Completed Startup
1. Angel (individual) 21-May-2012 $600K $600K Completed Startup
To view Carmolex’s complete valuation and funding history, request access »

Carmolex Executive Team (3)

Name Title Board Seat
Rafael Vélez MD Co-Founder, Chief Executive Officer & Board Member
Alexander Doemling Ph.D Co-Founder, Co-Chairman Scientific Advisory Board, Board Member & Chief Scientific Officer
Carlos Camacho Ph.D Co-Founder
To view Carmolex’s complete executive team members history, request access »

Carmolex Board Members (1)

Name Representing Role Since
Rafael Vélez MD Carmolex Co-Founder, Chief Executive Officer & Board Member
To view Carmolex’s complete board members history, request access »

Ready to get started?

Request a free trial

Carmolex FAQs

  • When was Carmolex founded?

    Carmolex was founded in 2012.

  • Who is the founder of Carmolex?

    Rafael Vélez MD, Alexander Doemling Ph.D, and Carlos Camacho Ph.D are the founders of Carmolex.

  • Who is the CEO of Carmolex?

    Rafael Vélez MD is the CEO of Carmolex.

  • Where is Carmolex headquartered?

    Carmolex is headquartered in Pittsburgh, PA.

  • What industry is Carmolex in?

    Carmolex’s primary industry is Biotechnology.

  • Is Carmolex a private or public company?

    Carmolex is a Private company.

  • What is Carmolex’s current revenue?

    The current revenue for Carmolex is .

  • How much funding has Carmolex raised over time?

    Carmolex has raised $2.35M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »